Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 7, Pages e41658
Publisher
Public Library of Science (PLoS)
Online
2012-07-24
DOI
10.1371/journal.pone.0041658
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diffuse large B Cell lymphoma: How can we cure more patients in 2012?
- (2012) Craig Moskowitz BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma
- (2012) Luis F. Porrata et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diffuse large B cell lymphoma with an interfollicular pattern of proliferation shows a favourable prognosis: a study of the Osaka Lymphoma Study Group
- (2012) Naoki Wada et al. HISTOPATHOLOGY
- Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
- (2011) A. A. Alizadeh et al. BLOOD
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma
- (2011) L. F. Porrata et al. HAEMATOLOGICA
- Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group
- (2011) Naoki Wada et al. HISTOPATHOLOGY
- Beclin 1 expression predicts favorable clinical outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2011) Jia-Jia Huang et al. HUMAN PATHOLOGY
- Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15
- (2011) Hideyuki Ishii et al. INTERNATIONAL JOURNAL OF CANCER
- Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy
- (2011) Yu Ri Kim et al. Journal of Hematology & Oncology
- The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
- (2011) R A Wilcox et al. LEUKEMIA
- The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma
- (2011) Ryan A. Wilcox et al. LEUKEMIA & LYMPHOMA
- Lymphoma classification: the quiet after the storm
- (2011) Stefano A. Pileri et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
- (2010) J. J. Huang et al. ANNALS OF ONCOLOGY
- Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
- (2010) Y. Lin et al. BLOOD
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphoproliferative Disorders After Solid Organ Transplantation—Classification, Incidence, Risk Factors, Early Detection and Treatment Options
- (2010) Gyula Végső et al. PATHOLOGY & ONCOLOGY RESEARCH
- Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story
- (2009) A. Bari et al. ANNALS OF ONCOLOGY
- Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
- (2009) R. A. Wilcox et al. BLOOD
- Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
- (2009) Isabelle Ray-Coquard et al. CANCER RESEARCH
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
- (2008) L. M. Morton et al. BLOOD
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started